US NAT yield: where are we after 2 years?

This publication has 16 references indexed in Scilit:

• Why is there such difficulty in defining the natural history of hepatitis C?
  Transfusion, 2000
• NAT and blood safety: what is the paradigm?
  Transfusion, 2000
• Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases
  Transfusion, 2000
• TRANSFUSION in the New Year
  Transfusion, 2000
• Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting
  The Lancet, 1999
• American Association of Blood Banks 50th annual meeting. Denver, Colorado, October 18–22, 1997. Abstracts
  Transfusion, 1997
• The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection
  Transfusion Medicine Reviews, 1997
• The Risk of Transfusion-Transmitted Viral Infections
  New England Journal of Medicine, 1996
• Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study
  Transfusion, 1995
• Application of Six Hepatitis C Virus Genotyping Systems to Sera from Chronic Hepatitis C Patients in the United States
  The Journal of Infectious Diseases, 1995